Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...

We spoke with Dr. Demetre Daskalakis, the director of the CDC’s National Center for Immunization and Respiratory Diseases, about the agency’s avian flu response.

The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...

Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...

Gluco6 is a cutting-edge supplement designed to optimize blood sugar regulation and alleviate nerve pain. Its unique f ...

Israelis Were Surprised to Discover Sinwar’s Body After Shooting Stopped The soldiers who killed Yahya Sinwar, a major target of Israel’s military campaign in Gaza, had not expected to run ...

According to the Food and Drugs Administration (FDA), the recall was initiated on Sept. 28, 2024, and is ongoing.

Bitter rivals are suddenly paying each other compliments, at least until there’s a Subway Series, if that happens. “It’s weird,” said the longtime Yankees announcer. By David Waldstein I ...